These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23356175)

  • 21. Mucus and MUC in asthma.
    Morcillo EJ; Cortijo J
    Curr Opin Pulm Med; 2006 Jan; 12(1):1-6. PubMed ID: 16357571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation.
    Ermund A; Meiss LN; Dolan B; Bähr A; Klymiuk N; Hansson GC
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29853489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of airway surface liquid volume by human airway epithelia.
    Boucher RC
    Pflugers Arch; 2003 Jan; 445(4):495-8. PubMed ID: 12548395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Hyaluronic Acid (HA) in Chronic Airway Diseases.
    Máiz Carro L; Martínez-García MA
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases.
    Banerjee R; Puniyani RR
    J Biomater Appl; 2000 Jan; 14(3):243-72. PubMed ID: 10656543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
    Restrepo RD
    Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucus hypersecretion in respiratory disease. Chair's introduction.
    Basbaum C
    Novartis Found Symp; 2002; 248():1-2. PubMed ID: 12568484
    [No Abstract]   [Full Text] [Related]  

  • 29. CLCA1 and TMEM16A: the link towards a potential cure for airway diseases.
    Brett TJ
    Expert Rev Respir Med; 2015 Oct; 9(5):503-6. PubMed ID: 26296094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
    Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G
    Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of airway surface liquid volume and mucus transport by active ion transport.
    Tarran R
    Proc Am Thorac Soc; 2004; 1(1):42-6. PubMed ID: 16113411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [BCL1 POLYMORPHISM OF GLUCOCORTICOID RECEPTOR GENE AND RESPIRATORY DISEASES].
    Prystupa LN; Garbuzova VY; Kmyta VV
    Lik Sprava; 2015; (1-2):43-8. PubMed ID: 26118026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathophysiological role of mucus production in inflammatory airway diseases.
    Lundgren JD; Vestbo J
    Respir Med; 1995 May; 89(5):315-6. PubMed ID: 7638364
    [No Abstract]   [Full Text] [Related]  

  • 34. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucoactive drugs.
    Balsamo R; Lanata L; Egan CG
    Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucus in chronic airway diseases: sorting out the sticky details.
    Cohn L
    J Clin Invest; 2006 Feb; 116(2):306-8. PubMed ID: 16453018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology.
    Hardy CL; King SJ; Mifsud NA; Hedger MP; Phillips DJ; Mackay F; de Kretser DM; Wilson JW; Rolland JM; O'Hehir RE
    Immunol Cell Biol; 2015 Jul; 93(6):567-74. PubMed ID: 25753271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchial epithelium as a target for innovative treatments in asthma.
    Gras D; Chanez P; Vachier I; Petit A; Bourdin A
    Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.